CervoMed Inc. Payments of Financing Costs
CervoMed Inc. (CRVO) reported Payments of Financing Costs of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2022-03-18
- CervoMed Inc. payments of financing costs for the quarter ending 2021-12-31 was $0.00.
- CervoMed Inc. payments of financing costs for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. payments of financing costs for the quarter ending 2020-12-31 was $0.00.
- CervoMed Inc. payments of financing costs for the quarter ending 2020-09-30 was $148.90K, a 85.65% increase year-over-year.
- CervoMed Inc. payments of financing costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CervoMed Inc. payments of financing costs for fiscal 2020 was $982.33K, a 503.29% increase from fiscal 2019.
- CervoMed Inc. payments of financing costs for fiscal 2019 was $162.83K, a 62.00% decline from fiscal 2018.
- CervoMed Inc. payments of financing costs for fiscal 2018 was $428.54K, a 240.17% increase from fiscal 2017.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $0.00 10-K · filed 2022-03-18 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-11 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $148.90K derived: sum of 2 quarters · filed 2022-03-18 | $744.10K derived: sum of 3 quarters · filed 2022-03-18 | $982.33K 10-K · filed 2022-03-18 |
| 2020-09-30 | $148.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $744.10K derived: sum of 2 quarters · filed 2021-11-10 | $982.33K 10-Q · filed 2021-11-10 | $982.33K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $595.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $833.43K 10-Q · filed 2021-08-11 | $833.43K derived: sum of 3 quarters · filed 2021-08-11 | $913.63K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $238.23K 10-Q · filed 2021-05-07 | $238.23K derived: sum of 2 quarters · filed 2021-05-07 | $318.44K derived: sum of 3 quarters · filed 2021-05-07 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $80.21K derived: sum of 2 quarters · filed 2021-03-17 | $162.83K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $80.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $162.83K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $82.62K 10-Q · filed 2020-08-07 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $0.00 derived: sum of 2 quarters · filed 2020-03-17 | $174.78K derived: sum of 3 quarters · filed 2020-03-17 | $428.54K 10-K · filed 2020-03-17 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $174.78K derived: sum of 2 quarters · filed 2019-11-08 | $428.54K 10-Q · filed 2019-11-08 | $456.54K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $174.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $428.54K 10-Q · filed 2019-08-08 | $456.54K derived: sum of 3 quarters · filed 2019-08-08 | $511.21K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $253.76K 10-Q · filed 2019-05-09 | $281.76K derived: sum of 2 quarters · filed 2019-05-09 | $336.43K derived: sum of 3 quarters · filed 2019-05-09 | $192.10K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $82.67K derived: sum of 2 quarters · filed 2019-03-19 | -$61.67K derived: sum of 3 quarters · filed 2019-03-19 | $125.98K 10-K · filed 2019-03-19 |
| 2017-09-30 | $54.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$89.67K derived: sum of 2 quarters · filed 2018-11-13 | $97.98K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$144.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $43.31K 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | $187.65K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $54.35K 10-K · filed 2018-04-02 | |||
| 2015-12-31 | $15.31K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |